Skip to content

A multicenter study on the clinical and immunological characteristic of STAT1 mutation

A multicenter study on the clinical and immunological characteristic of STAT1 mutation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104312
Enrollment
Unknown
Registered
2025-06-15
Start date
2024-05-27
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

STAT1 mutations

Interventions

STAT1 mutant GOF group:none
STAT1 mutant LOF group:none

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diagnosed or suspected STAT1 mutant disease: (1) Clinical conformity with STAT1 gain-of-function (GOF) or loss-of-function (LOF) manifestations; (2) Genetic testing suggests STAT1 gene mutations; (3) Laboratory functional testing showed abnormal STAT1 functional testing ((1)+(2)+(3) for a definite diagnosis; (1)+(2) is definitive if the mutation is a reported GOF/LOF mutation, otherwise it is suspected) 2. Complete case information: reliable case information since the onset of the disease can be found or inquired

Exclusion criteria

Exclusion criteria: 1.If any of the above enrollment indicators is negative, the group will not be enrolled.

Design outcomes

Primary

MeasureTime frame
Infection;Autoimmune disease;Survival cycle;HSCT survival rate;Tumor incidence;

Secondary

MeasureTime frame
Demographic data;Infection pathogen profiles;

Countries

China

Contacts

Public ContactAn Yunfei

Children's Hospital of Chongqing Medical University

anyf82@aliyun.com+86 13896187845

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026